The topic of my master’s thesis evolved not only from my own interest and fascination of jacquard weaving. A little bit of luck contributed to the final outcome of this study as well. At an early point of my study, I wanted to discuss the material and col-our design of woven textiles. I considered various ways on how to approach the subject from a fresh and meaningful point of view. In the beginning of the spring of 2014, I spent three months on an internship at the Italian weaving mill Lodetex. Lodetex is specialized in the production of jacquard fabrics for furnishing markets. I decided that doing my thesis in collaboration with Lodetex would be a viable continuum after working in the company as an intern. I discussed the matter with owner Luca Farhanghi and he agreed that a thesis collaboration would be interesting and beneficial for the both of us. He informed me about a few production lines that the company planned on developing. One of these lines related to clipped designs. To me, the development of clipped designs seemed like a fascinating and interesting topic to research. Since I had already designed two clipped designs during my internship, I realized that the weaving process of these fabrics required more advanced technical understanding in interwoven structure of cloth. Therefore, this project gave me a chance to improve my skills in artistic expression as well as develop my knowledge in designing, weaving and finishing of clipped cloths.
Injectable steroids are injected into muscle tissue, not into the veins. They are slowly released from the muscles into the rest of the body, and may be detectable for months after last use. Injectable steroids can be oil-based or water-based. Injectable anabolic steroids which are oil-based have longer half-life than water-based steroids. Both steroid types have much longer half-lives than oral anabolic steroids. And this is proving to be a drawback for injectables as they have high probability of being detected in drug screening since their clearance times tend to be longer than orals. Athletes resolve this problem by using injectable testosterone early in the cycle then switch to orals when approaching the end of the cycle and drug testing is imminent.
Another point I’d like to make for people worried about a link between high testosterone and prostate cancer is that it just doesn’t make sense. Prostate cancer becomes more prevalent in men as they age, and that’s also when their testosterone levels decline. We almost never see it in men in their peak testosterone years, in their 20s for instance. We know from autopsy studies that 8% of men in their 20s already have tiny prostate cancers, so if testosterone really made prostate cancer grow so rapidly — we used to talk about it like it was pouring gasoline on a fire — we should see some appreciable rate of prostate cancer in men in their 20s. We don’t. So, I’m no longer worried that giving testosterone to men will make their hidden cancer grow, because I’m convinced that it doesn’t happen.